MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Rituximab (Primary)
- Indications Microscopic polyangiitis; Wegener's granulomatosis
- Focus Therapeutic Use
- Acronyms MAINRITSAN 2
- 01 Mar 2018 Status changed from active, no longer recruiting to completed.
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 18 Nov 2016 Planned End Date changed from 1 Oct 2017 to 1 Dec 2016.